Venography during endoscopic injection sclerotherapy of esophageal varices.
Utilizing an equal mixture of 5% sodium morrhuate and 60% renografin, we studied four patients during a total of nine sessions of injection sclerotherapy of esophageal varices to determine radiographically the fate of injected sclerosant. Despite attempted intravariceal injections, 44% resulted in local and presumably paravariceal accumulation of contrast material within the esophageal wall. During 42% of injections, contrast material was rapidly cleared in a cephalad direction and proximal balloon compression of the esophagus did not prevent cephalad flow of sclerosant. In 14% the injected material was rapidly cleared in a caudal direction toward the gastric veins. This technique may be useful in future evaluations of the efficacy of various methods of injection sclerotherapy of esophageal varices.
D003287:Contrast Media; D003973:Diatrizoate / Q000031:analogs & derivatives; D003974:Diatrizoate Meglumine; D004338:Drug Combinations; D004932:Esophageal and Gastric Varices / Q000000981:diagnostic imaging / Q000628:therapy*; D004945:Esophagoscopy; D004947:Esophagus / Q000098:blood supply; D005227:Fatty Acids / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000000981:diagnostic imaging / Q000628:therapy; D006801:Humans; D010690:Phlebography; D012976:Sodium Morrhuate / Q000627:therapeutic use*; D013270:Stomach / Q000098:blood supply
D003287:Contrast Media; D004338:Drug Combinations; D005227:Fatty Acids; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D012976:Sodium Morrhuate; C027278:urovision